Mycobacterium tuberculosis rpoB gene DNA sequencing:: implications for detection of rifamycin resistance

被引：3

作者：

Sintchenko, V ^{[1
]}

Jelfs, PJ ^{[1
]}

Chew, WK ^{[1
]}

Gilbert, GL ^{[1
]}

机构：

[1] Westmead Hosp, Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol, Lab Serv, Westmead, NSW, Australia

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1999年 / 44卷 / 02期

关键词：

D O I：

10.1093/jac/44.2.294

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：294 / 295

页数：2

共 7 条

[1] MUTATION POSITION AND TYPE OF SUBSTITUTION IN THE BETA-SUBUNIT OF THE RNA-POLYMERASE INFLUENCE IN-VITRO ACTIVITY OF RIFAMYCINS IN RIFAMPICIN-RESISTANT MYCOBACTERIUM-TUBERCULOSIS [J].

BODMER, T ;

ZURCHER, G ;

IMBODEN, P ;

TELENTI, A .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 35 (02) :345-348

[2] Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan [J].

Ohno, H ;

Koga, H ;

Kohno, S ;

Tashiro, T ;

Hara, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) :1053-1056

[3] Evaluation of the INNO-LiPA Rif.TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin [J].

Rossau, R ;

Traore, H ;

DeBeenhouwer, H ;

Mijs, W ;

Jannes, G ;

DeRijk, P ;

Portaels, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) :2093-2098

[4]

SINTCHENKO V, 1999, IN PRESS PATHOLOGY, V31

[5] DETECTION OF RIFAMPICIN-RESISTANCE MUTATIONS IN MYCOBACTERIUM-TUBERCULOSIS [J].

TELENTI, A ;

IMBODEN, P ;

MARCHESI, F ;

LOWRIE, D ;

COLE, S ;

COLSTON, MJ ;

MATTER, L ;

SCHOPFER, K ;

BODMER, T .

LANCET, 1993, 341 (8846) :647-650

[6] Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis [J].

Williams, DL ;

Spring, L ;

Collins, L ;

Miller, LP ;

Heifets, LB ;

Gangadharam, PRJ ;

Gillis, TP .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (07) :1853-1857

[7] Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis [J].

Yang, B ;

Koga, H ;

Ohno, H ;

Ogawa, K ;

Fukuda, M ;

Hirakata, Y ;

Maesaki, S ;

Tomono, K ;

Tashiro, T ;

Kohno, S .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (05) :621-628

← 1 →